Pharmaceutical News

"), a wholly-owned subsidiary of Cardinal Health, Inc. , announced today that the offer by Cardinal Health Canada to acquire all of the outstanding common shares of Futuremed Healthcare Products Corporation for CAD 13,985,153 Common Shares have been validly deposited to the Offer.A As all of the conditions to the Offer have been satisfied, the ... (more)

John Paulson's flagship Paulson Advantage Fund was down 50% in 2011 and he clearly spent Q4 "derisking" his portfolio across the board .

The $165-million friendly takeover of Futuremed Healthcare Products Corp. by a subsidiary of U.S.-based Cardinal Health Inc.

Bayer Healthcare, a U.S. subsidiary of Bayer AG, a German-based chemical and pharmaceutical company, said the acquisition will allow the company to have a broader range of products, which currently include farm hygiene premise sprays and dusts.

Pfizer and one of its subsidiaries reached a settlement with Intelliject and Sanofi-Aventis to allow a rival to the EpiPen auto-injector, called e-cue, to be launched in November 2012, Pfizer announced today.

Teva Pharmaceutical Industries Ltd 's stock had its "strong-buy" rating reiterated by analysts at Needham & Company in a research report issued to clients and investors on Thursday.

Dey Pharma LP is a specialty pharmaceutical division of the Southpointe-based Mylan Inc.

Watson Pharmaceuticals Incorporated was upgraded by Buckingham Research from a "neutral" rating to a "buy" rating in a research note issued on Wednesday.

BOSTON -- Some of Wall Street's biggest investors, including hedge fund honcho Steven Cohen, are jockeying for profits in the raging hepatitis C drug-stock rally.

BioSante Pharmaceuticals Inc. rose 27 percent after the testosterone replacement therapy it developed for men won U.S. regulatory approval.

Teva Pharmaceutical Industries Ltd. said fourth-quarter profit rose 23 percent as last year's acquisition of Cephalon Inc.

PITTSBURGH, Feb. 14, 2012 /PRNewswire/ -- Mylan Inc. today commented on its response to the current shortage of preservative-free Methotrexate Injection.

A developing medical theory that hepatitis C can be overcome with the same type of drug cocktails that tamed HIV may drive acquisition strategies as companies try to anticipate which products work best with other medicines.

Hospira, Inc. Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent /PRNewswire/ -- Hospira, Inc.

The 10-second takeaway For the quarter ended Dec. 31 , Watson Pharmaceuticals met expectations on revenues and beat expectations on earnings per share.

Good morning. My name is Therese, and I will be your conference operator today. At this time, I would like to welcome everyone to the Watson Pharmaceuticals Earnings Conference Call.

Watson Pharmaceuticals Inc, the world's fifth-largest generic drugmaker, lifted its full-year earnings forecast on Tuesday as it benefits from a generic version of the big-selling Lovenox blood clot prevention drug.

Full Year 2011 Non-GAAP EPS Increases 39% To $4.77; GAAP EPS $2.06 - - Fourth Quarter 2011 Net Revenue $1.54 Billion - - Fourth Quarter 2011 Non-GAAP EPS $1.77; GAAP EPS $0.75 - PARSIPPANY, N.J., Feb.

Watson Pharmaceuticals Inc. recently confirmed that it has filed an abbreviated new drug application with the US Food and Drug Administration to market the generic version of Bayer 's oral contraceptive, Beyaz.

Bristol-Myers Squibb said it has completed a $2.5 billion acquisition of Inhibitex Inc.